Browse By: Country ι Category ι Tag
Home  »  Kelly Scientific Publications

Kelly Scientific Publications Market Research Reports

Kelly Scientific Publications is an international market research publishing company that specialises in pharmaceutical, biotechnology and medical diagnostic industries. We provide business intelligence, market insights and competitor analysis to serve business leaders in industry, biotech, pharmaceutical, government departments and hi-tech organisations. 

Clients benefit from professionally written reports that provide:
  • Up-to-date company and market data
  • Company profiles, SWOT analysis, company financials
  • Product lines, portfolios, pipeline and R&D analysis
  • High numbers of tables and figures 
  • Independent expert opinions and in-depth analysis 
  • Major market, economic, scientific and technological developments
  • Emerging trends, future forecasts and market highlights



Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons, Product Pipelines, Trends, Key Players, Regulations and Strategic Outlook
Biosimilars are highly-similar versions of biological drugs that are indicated for cancer, kidney disorders and a wide range of autoimmune diseases. Originator biologics are the most expensive drugs in the pharmaceutical industry and many of them cost nearly $100,000 per patient per year.
Published Date: Aug 2015
Published By: Kelly Scientific Publications

Price: $3400
Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
Precision or personalized healthcare is revolutionizing how medicine is practiced today. Scientific advances have identified a wealth of genetic and protein biomarkers that can be used to identify and associate certain disease states with specific individuals, and now can also predict how patients will respond to particular drugs. 
Published Date: Jul 2015
Published By: Kelly Scientific Publications

Price: $3400
Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 265 tables & figures within 182 pages. The Chinese biopharmaceutical market is presented as follows:
Published Date: Jul 2015
Published By: Kelly Scientific Publications

Price: $3400
Global & Usa Cancer Immunotherapy Market Analysis To 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells
This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic therapeutics cannot cure cancer and yet in 2014, the overall market for cancer therapeutics stood at about $84.3 billion. Any drug that can provide a reasonable survival of more than five years for the cancer patients can achieve a blockbuster status. Within the cancer therapeutics, the immunotherapeutic drugs have gained worldwide acceptance, because they are targeted drugs targeting only the cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating about $41.0 billion in 2014 alone. This report describes the evolution o
Published Date: Apr 2015
Published By: Kelly Scientific Publications

Price: $3400
Global Cosmetic Surgery and Service Market Report 2015-2019
KellySciPub’s cutting-edge report Global Cosmetic Surgery & Services Market Analysis 2015-2019 is the latest analysis on this vertically growing market. It is currently worth over $20 billion and is set to rise to over $27 billion by 2019. This comprehensive report is supported by 60 tables & figures over 275 pages and is presented as follows:  The global market for cosmetic surgery services by the following sub-categories are presented: By Segment (Body Contouring, Facial Reconstruction/Rejuvenation, Cosmetic Implants) By Geography (North America, Europe, Asia/Pacific, Latin America) By Product Segment (Facial injectables, Botox, Dermafillers, Neuromodulators) By Energy Based and Other Devices (Home-use Aesthetic Devices) By Company (e.g Allergen, Mentor, Ga
Published Date: Mar 2015
Published By: Kelly Scientific Publications

Price: $3400
Global Transdermal Drug Delivery Market To 2020 Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment And Swot Investigation
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables & figures over 280 pages. This report is presented as follows: By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO) By Geography (Global, USA) By Parent Market (Drug Delivery Systems, Advanced Drug Delivery Systems) By Sub-market (Generics, Women’s Health, Analgesics, Neuropathic Pain) A wealth of financial data & business strategy information is provided including: Up-to-date company financials, sales & revenue figures Revenue and market forecasts Business model strategies for drug delive
Published Date: Feb 2015
Published By: Kelly Scientific Publications

Price: $3400
Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables & figures over 254 pages. The personalized medicine (global) market is presented as follows: By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics) A wealth of financial data & business strategy information is provided including: Company financials, sales & rev
Published Date: Jan 2015
Published By: Kelly Scientific Publications

Price: $3400
Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)
GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis)” by Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment.    Cancer biomarkers are molecular or genetic moieties (e.g., cells, proteins/peptides, genetic mutations, gene products, enzymes, or hormones) that not only are readily identifiable, but easily quantified in the lab setting. They function primarily to identify or correlate sign
Published Date: May 2014
Published By: Kelly Scientific Publications

Price: $3400
Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 263 tables & figures over 224 pages. The personalized medicine (global) market is presented as follows: • By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD) • By Geography (US, UK, EU) • By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services) • By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics) A wealth of financial data & business strategy information is provided including: Up-to-date com
Published Date: Mar 2014
Published By: Kelly Scientific Publications

Price: $3842
Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
Pharmaceutical Industry China – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 199 tables & figures within 153 pages. The Chinese biopharmaceutical market is presented as follows: By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression) A weal
Published Date: Mar 2014
Published By: Kelly Scientific Publications

Price: $2754
Pharmaceutical Market China Q2 2013
Pharmaceutical Industry China Q2·2013 – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 196 tables & figures within 142 pages. The Chinese biopharmaceutical market is presented as follows:   By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression
Published Date: Nov 2013
Published By: Kelly Scientific Publications

Price: $2700
Pharmaceutical Market India Q2 2013
Pharmaceutical Market India: A Comprehensive Industry Analysis provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 330 tables & figures. The Indian pharmaceutical market (IPM) is presented as follows:   By Company (e.g., CIPLA, SUN PHARMA, RANBAXY, PIRAMAL, ZYDUS CADILA, MANKIND, LUPIN) By Segment (FORMULATIONs, APIs, BIOSIMILARs, CRAMS) By Therapeutic Area (e.g., Cardiovascular, Diabetes, Cancer, Respiratory) By Disease Category (Acute, Chronic)   A wealth of financial information is provided including:   Up-to-date company financials, sales & revenue figures India GDP, economic growth, ex
Published Date: Nov 2013
Published By: Kelly Scientific Publications

Price: $2700
Personalized Medicine & Companion Diagnostic Market Q2 2013
Personalized Medicine and Companion Diagnostic Market- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” provides you with a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 261 tables & figures over 205 pages. The personalized medicine (global) market is presented as follows:   By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)  
Published Date: Nov 2013
Published By: Kelly Scientific Publications

Price: $3766
Personalized Medicine and Companion Diagnostic Market Q3 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 261 tables & figures over 206 pages. The personalized medicine (global) market is presented as follows: By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics) A wealth of financial data & business strategy information is provided including: Up-to-date company financials, sales
Published Date: Nov 2013
Published By: Kelly Scientific Publications

Price: $3841
Pharmaceutical Industry in China Q3 2013 - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
This report tackles not only global pharmaceutical company interest in China but also home grown companies and their battle for position. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities.  The Chinese Pharmaceutical market is currently the third greatest pharma market globally, after the US and Japan, and in 2011 was worth $x. It is forecast to increase dramatically to $x by 2015 and increase its dominance as a leading player in Asia. As the current third market leader it is predicted that the Chinese pharma market will be the main competitor of the US by 2020.  This report describes the current therapeutics that are propelling the biopharmaceutical market in China. It examines the current economic
Published Date: Nov 2013
Published By: Kelly Scientific Publications

Price: $2754
Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013
“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle within domestic and international therapeutic markets. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities.   The Indian pharmaceutical market is set to become the eight largest pharma market globally by 2015. This report describes the current therapeutics that are propelling the biopharmaceutical market in India and the main players in the industry. It examines the current economic climate and how India compare
Published Date: Nov 2013
Published By: Kelly Scientific Publications

Price: $2593
Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 261 tables & figures over 205 pages. The personalized medicine (global) market is presented as follows: By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics) A wealth of financial data & business strategy information is provided including: Up-to-date company financials, sales
Published Date: Jul 2013
Published By: Kelly Scientific Publications

Price: $3679
Pharmaceutical Industry in China Q2 2013 - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
Pharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 196 tables & figures within 142 pages. The Chinese biopharmaceutical market is presented as follows: By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression) A wealth o
Published Date: Jul 2013
Published By: Kelly Scientific Publications

Price: $2575
BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 154 tables & figures. The Chinese biopharmaceutical market is presented as follows: By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression) A wealth of financial informatio
Published Date: May 2013
Published By: Kelly Scientific Publications

Price: $2593
Personalized Medicine- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
  This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 239 tables & figures. The personalized medicine (global) market is presented as follows:   By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, CELERA, MYRIAD) By Geography (US, UK, EU) By Segment (Targeted therapeutics, Esoteric tests, Esoteric lab services) By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)   A wealth of financial data & business strategy information is provided including:   Up-to-date company financials, sales & revenue figures Business Model Strategies for Diagnostic, Phar
Published Date: May 2013
Published By: Kelly Scientific Publications

Price: $3617

Back To Top